Family Medicine · Nantucket, MA
NPI
1427062959
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
57 Prospect St
Nantucket, MA, 02554
Phone (508) 228-4748
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
7,861 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Diane R Pearl prescribed most often to Medicare patients was Atorvastatin Calcium, with 778 prescriptions and refills. In total Diane R Pearl wrote 7,861 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 778 | 2,199 | 234 | $8,526 |
| Metoprolol Succinate Generic | 338 | 883 | 102 | $6,306 |
| Amlodipine Besylate Generic | 309 | 814 | 89 | $1,947 |
| Levothyroxine Sodium Generic | 275 | 704 | 69 | $2,797 |
| Losartan Potassium Generic | 266 | 701 | 74 | $2,970 |
| Lisinopril Generic | 255 | 672 | 70 | $1,749 |
| Eliquis Apixaban | 251 | 362 | 45 | $202K |
| Omeprazole Generic | 202 | 524 | 57 | $1,827 |
| Gabapentin Generic | 163 | 247 | 36 | $1,433 |
| Rosuvastatin Calcium Generic | 155 | 419 | 42 | $4,638 |
| Jardiance Empagliflozin | 143 | 186 | 25 | $106K |
| Sertraline Hcl Generic | 107 | 203 | 23 | $976 |
| Metformin Hcl Er Metformin Hcl | 105 | 223 | 28 | $994 |
| Xarelto Rivaroxaban | 105 | 236 | 25 | $129K |
| Lorazepam Generic | 104 | 110 | 31 | $305 |
Brand drugs: 1,281 claims; generic drugs: 6,536 claims; opioid claims: 206.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Diane R Pearl were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.